Dronabinol Versus Standard Ondansetron Antiemetic Therapy in Preventing Delayed-Onset Chemotherapy-Induced Nausea and Vomiting

Inclusion Criteria

• •Histological evidence of non-CNS malignancy (primary or metastatic disease) and lymphomas which are not involving the bone marrow.
• •Undergoing single or multiple days of chemotherapy as long as Day 1 chemotherapy includes:
• •1. a moderate-to-high emetogenic regimen, or
• •2. oxaliplatin at doses employed for treatment of colon cancer, or
• •3. the combination of AC \[AdriamycinÒ (60 mg/m2) with cyclophosphamide (600 mg/m2)\] as to be used for the chemotherapeutic drug regimen involving taxanes in the treatment of breast cancer.